No, not yet, I want to ask my cardiologist a number of questions first.
Regarding the slow uptake of new surgical products investors should also be aware that representatives of the companies supplying surgical prosthesis are usually also in theatre with the surgical team. This leads to brand loyalty in much the same way as experienced in the vehicle industry where owners are often reluctant to change brands.
Ann: DurAVR First In Human Patient 6 Month Study Follow Up, page-32
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.27 |
Change
0.360(6.09%) |
Mkt cap ! $97.17M | |||
| Open | High | Low | Value | Volume |
| $5.93 | $6.30 | $5.91 | $107.9K | 17.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3500 | $6.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.27 | 200 | 1 |
View Market Depth
| Last trade - 15.42pm 27/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |